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Pyrimidine nucleotides play an important role in the biosynthesis of activated nucleotide
sugars (NDP-sugars). NDP-sugars are the precursors of structural polysaccharides in
bacteria, including capsule, which is a major virulence factor of the human pathogen S.
pneumoniae. In this work, we identified a spontaneous non-reversible mutant of strain
D39 that displayed a non-producing capsule phenotype. Whole-genome sequencing
analysis of this mutant revealed several non-synonymous single base modifications,
including in genes of the de novo synthesis of pyrimidines and in the −10 box of capsule
operon promoter (Pcps). By directed mutagenesis we showed that the point mutation
in Pcps was solely responsible for the drastic decrease in capsule expression. We
also demonstrated that D39 subjected to uracil deprivation shows increased biomass
and decreased Pcps activity and capsule amounts. Importantly, Pcps expression is
further decreased by mutating the first gene of the de novo synthesis of pyrimidines,
carA. In contrast, the absence of uracil from the culture medium showed no effect on
the spontaneous mutant strain. Co-cultivation of the wild-type and the mutant strain
indicated a competitive advantage of the spontaneous mutant (non-producing capsule)
in medium devoid of uracil. We propose a model in that uracil may act as a signal for the
production of different capsule amounts in S. pneumoniae.
Keywords: Streptococcus pneumoniae, spontaneous mutations, uracil metabolism, capsule biosynthesis, gene
expression
INTRODUCTION
Streptococcus pneumoniae is a deadly human pathogen. This bacterium that resides in the human
nasopharynx can, when the host immune system is debilitated, migrate to and infect normally
sterile niches, such as the lower respiratory tract (bronchi and lungs), middle ear, meninges
and blood (Kadioglu et al., 2008). The fluctuating environments in the host elicit different gene
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expression patterns in S. pneumoniae, leading to different
phenotypes (Orihuela et al., 2004; LeMessurier et al., 2006;
Oggioni et al., 2006; Pettigrew et al., 2014). The phenotypic
variation of capsule amounts (i.e., opaque and transparent phase
variation) or the non-expression of capsule (non-encapsulation)
are remarkable examples of pneumococcal adaptation to different
microenvironments (Kim et al., 1999; Hammerschmidt et al.,
2005; Li et al., 2016). In humans, non-encapsulated isolates of
S. pneumoniae occur almost exclusively on mucosal surfaces
(up to 15% of the pneumococcal nasopharyngeal isolates are
non-encapsulated), when compared to their absence in invasive
disease (van der Windt et al., 2012), and are associated with
outbreaks of conjunctivitis (van der Windt et al., 2012; Schaffner
et al., 2014; Shainheit et al., 2015). The appearance of non-
encapsulated strains may result from the entire replacement of
the capsule (cps) locus or, when the capsule operon is maintained,
from reversible or irreversible mutations within capsule locus or
capsule locus promoter (Moscoso and García, 2009; Yother, 2011;
Schaffner et al., 2014; Shainheit et al., 2015; Wen et al., 2016).
Mechanisms of adaptation leading to pneumococcal irreversible
mutations and thereof to readjustment of regulatory networks
have been described (Claverys et al., 2000; Hakenbeck et al.,
2001; Pericone et al., 2002; Stevens and Sebert, 2011). These
mechanisms include horizontal gene transfer and homologous
recombination, transposition of insertion sequences (ISs), gene
duplication, rearrangement of short-sequence DNA repeats
(namely RUP and BOX elements), and oxidative damage-
mediated responses (Claverys et al., 2000; Hakenbeck et al., 2001,
2012; Hoskins et al., 2001; Tettelin et al., 2001; Pericone et al.,
2002; Lanie et al., 2007; Stevens and Sebert, 2011). The aptitude
to acquire new mutations is further corroborated by the findings
showing that S. pneumoniae accumulates beneficial mutations at
a rate of 4.8 × 10−4 per genome per generation time, during
single-colony serial transfer (Stevens and Sebert, 2011), a value
similar to that obtained for E. coli by Perfeito et al. (2007).
The present study started with the identification of a non-
reversible D39 spontaneous mutant that produces negligible
to no capsule, similar to its non-encapsulated derivative R6,
but containing all the genes of the capsule locus, including
the cps2ABCDETFGH genes, which are deleted in strain R6.
This isolate arose in cultures plated on solid medium, together
with D39 encapsulated colonies. Capsule has been recognized
as a condition sine qua non of virulence in S. pneumoniae.
Hence, regulation of its synthesis is central to the ability of
the pneumococcus to cause invasive disease (Kim et al., 1999;
Llull et al., 2001; Carvalho, 2012). The involvement of the
transcriptional regulators CcpA and CpsR, pyruvate oxidase
(SpxB) and the tyrosine phosphoregulatory system (CpsBCD),
in the control of pneumococcal capsule production has been
Abbreviations: ABC, ATP-binding cassette; CDM, chemically defined medium;
CFU, colony-forming unit; dTTP, deoxythymidine triphosphate; dTTP-Rha,
deoxythymidine triphosphate rhamnose; dUTP, deoxyuridine triphosphate;
Glc, glucose; GlcUA, glucuronic acid; NDP-sugars, nucleoside diphosphate
sugars; PTS, phosphoenolpryruvate:carbohydrate phosphotransferase system; Rha,
rhamnose; UDP, uridine diphosphate; UDP-Glc, uridine diphosphate glucose;
UDP-GlcUA, uridine diphosphate glucuronic acid; UMP, uridine monophosphate;
UTP, uridine 5′-triphosphate.
postulated (Weiser et al., 2001; Giammarinaro and Paton, 2002;
Morona et al., 2006; Ramos-Montañez et al., 2008; Carvalho
et al., 2011, 2013a; Carvalho, 2012; Geno et al., 2014; Nourikyan
et al., 2015; Echlin et al., 2016; Wu et al., 2016). Furthermore,
DNA inversions among methyltransferase genes in restriction-
modification (R-M) locus systems have been shown to modulate
capsule phase variation in the pneumococcus (Manso et al.,
2014; Li et al., 2016). Despite these recent advances, a true
understanding of the mechanisms connecting type 2 capsule
production and central metabolism in S. pneumoniae D39
remains unclear.
The capsule of strain D39 is formed by repeating units of
glucose (Glc), glucuronic acid (GlcUA) and rhamnose (Rha)
in the proportion of 1:2:3 (Iannelli et al., 1999). The sugar
constituents are activated by uridine 5’-triphosphate (UTP),
yielding uridine diphosphate glucose (UDP-Glc) and uridine
diphosphate glucuronic acid (UDP-GlcUA), and deoxythymidine
triphosphate (dTTP), yielding deoxythymidine diphosphate
rhamnose (dTDP-Rha) (Iannelli et al., 1999). In several
Gram-positive microorganisms, UTP is produced from uridine
monophosphate (UMP) in the salvage pathway of pyrimidine
biosynthesis (Kilstrup et al., 2005). However, the precursors
for UMP production may be synthesized endogenously in
the pathway of de novo synthesis of pyrimidines or from
uracil or uridine supplied exogenously (Kilstrup et al., 2005).
Previously, studies have shown a connection between the cellular
pool of UDP-glucose and capsule production (Hardy et al.,
2000, 2001). Additionally, a link between the pyrimidine uracil
metabolism and capsule production in strain D39 has been
surmised (Carvalho, 2012; Carvalho et al., 2013b). In this work,
we show that the non-producing capsule phenotype of a D39
spontaneous mutant (D39SM) isolated in our laboratory, which
maintains all genes of the capsule operon of strain D39, can
be ascribed to a point mutation in the −10 box element of the
capsule (cps) promoter. Besides this mutation, other mutations
in D39SM were detected by whole-genome sequencing analysis,
including single-nucleotide polymorphisms in 37.5% of the
de novo pyrimidine synthesis genes (carA, carB, and pyrDa).
In addition, by resorting to growth characterization, capsule
promoter expression and quantification, and transcriptome
analysis of D39 and its derivative strains in the presence or
absence of uracil, a link between pyrimidine metabolism and
capsule was shown. Accordingly, reconstitution of the D39SM
carA point mutation in the D39 background rendered a strain
with a significantly lower capsule promoter expression, when
uracil was absent from the medium. In light of these results, we
speculate that the stressful condition triggering the mutations
in D39 changed UMP/UTP availability, leading to the non-
encapsulated capsule phenotype. Considering this assumption,
we analyzed the growth profiles of D39 and D39SM in co-
cultivation in medium with or without uracil and observed that
in uracil-deprived conditions the non-encapsulated phenotype
is a competitive advantage. Additionally, we investigated how
capsule production and growth of S. pneumoniae responded
to the presence and absence of uracil. Based on our findings
we propose that sensing of uracil is one means by which S.
pneumoniae alters capsule production, and thus, virulence.
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MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
for Strain Isolation
Strains and plasmids used in this study are shown in Table 1.
Streptococcus pneumoniae strains were routinely grown in M17
agar containing 0.5% glucose and 1% (vol/vol) defibrinated
sheep blood (Probiológica, Portugal) or as standing cultures
without aeration in M17 broth (DifcoTM) supplemented with
0.5% glucose, at 37◦C. Stocks and working stocks of isolated
strains were prepared as described in (Carvalho et al., 2013b).
When appropriate, 2.5µg mL−1 chloramphenicol, 0.25µg mL−1
erythromycin, 15 µg mL−1 trimethoprim or 2.5 µg mL−1
tetracycline were added to the medium. E. coli EC1000 was
grown in Todd-Hewitt broth in a shaking incubator at 37◦C;
erythromycin was used at a concentration of 120 µg mL−1.
Lactococcus lactisNZ9000 was grown as standing cultures in TSB
medium at 30◦C; chloramphenicol and erythromycin were used
at concentrations of 5 and 4 µg mL−1, respectively.
The D39 spontaneous mutant (D39SM) was isolated in our
laboratory by plating out a GM17 liquid grown working stock of
strain D39 on GM17-agar plates that resulted in the appearance
of two colony phenotypes: large and opaque (encapsulated D39)
and small and transparent (non-encapsulated D39SM), in the
proportion of circa 100:1, respectively, after an overnight growth
at 37◦C and 5% (vol/vol) CO2. Both isolated strains were then
purified by two sequential passage steps; in each step, one single
colony of each isolate was selected and streaked onto GM17-agar
plates. Genomic DNA was extracted from each strain and their
whole genome was sequenced as described below.
Growth Conditions for Physiological
Studies
Streptococcus pneumoniae was grown in the chemically defined
medium (CDM) described in (Carvalho et al., 2013b), which
contains 10mg L−1 uracil (82µM). S. pneumoniae cultures were
started at an initial optical density at 600 nm (OD600) of 0.05–
0.06 by addition of preculture cells harvested in exponential
phase (OD600 0.8–1.0), centrifuged and suspended in fresh
CDM without uracil. Cultivations were performed in static
rubber-stoppered bottles at 37◦C without pH control (initial pH
6.5). Glucose 1% was used as the carbon source. Growth was
monitored by measuring OD600 every hour. Maximum specific
growth rates (µmax) were calculated through linear regressions
of the plots of ln(OD600) versus time during the exponential
growth phase. The effect of uracil deprivation on growth of
the pneumococcus strains was assessed by cultivating cells as
above, except that uracil was omitted from the medium. For
each growth condition at least three independent experiments
were performed. The plotted growth curves throughout the
manuscript are from a representative experiment and the error
in each point was in all cases below 15%.
For the complementation studies S. pneumoniae cells were
grown in 250 µL CDM supplemented or not with uracil (10mg
L−1) in 96-well microtiter plates, at 37◦C. Cultures were started
at an initial OD600 of 0.1, by addition of an exponentially
growing preculture suspended in fresh CDM without uracil,
and monitored every 30min at 600 nm with a MultiSkan GO
plate reader (ThermoScientific). Optical densities at 600 nm were
registered by the SkanIt Software 3.2 (ThermoScientific). Nisin (0
and 2 ng mL−1) was added at time zero.
Intraspecies Competition Growth
Experiments
D39 and D39SM were grown in CDM supplemented or not
with uracil (10mg L−1) in monoculture or co-culture. Both
monocultures and co-cultures were started at an initial OD600
of 0.06 ± 0.03 by addition of exponentially growing precultures
suspended in fresh CDM without uracil, as described above. In
the co-culture experiments, with and without uracil, D39 and
D39SMwere inoculated at a cell ratio of 4:1, 1:1, and 1:4. For each
condition at least three independent growth experiments were
performed. The plotted growth curves are from a representative
experiment and the error in each point was in all cases below 15%.
Colony forming units per mL (CFUs mL−1) of D39 and D39SM
were determined at time-point zero of inoculation (OD600 of
0.06 ± 0.03) as follows: suspensions were diluted 1,000 times
in CDM without uracil and plated (2 µL) in M17 blood agar
containing 0.5% glucose. For the determination of strain relative
abundance, samples in mid-exponential phase (OD600 of 0.48 ±
0.05) were collected, diluted 100 times and plated (100 µL) in
M17 blood agar containing 0.5% glucose. Plated cells were always
grown at 37◦C in a 5% (vol/vol) CO2 incubator. The estimation
of the relative abundances of the D39 and D39SM populations
was determined by cell counting (CFUs mL−1). Colonies of each
strain were selected on the basis of their phenotypic appearance
on plate, i.e. D39 colonies are opaque and bigger than D39SM
colonies, which are also transparent.
Plate Scanning
All the plates were scanned with white light epi-illumination
and stored as digitized image files with a Molecular Imager R©
ChemiDocTM XRS+ Imaging System (Bio-Rad). The Quantity
one software package was used to adjust the contrast, thus
enhancing the visualization of the colonies on the plates.
Molecular Techniques
Chromosomal DNA isolation was performed according to the
procedure of Johansen and Kibenich (1992) or alternatively, with
the NZY Tissue gDNA Isolation kit from NZYTech. Plasmid
isolation was carried out using plasmid isolation kits from
Roche or Qiagen. Pwo DNA polymerase (Roche), Phusion DNA
polymerase (Thermo Scientific), T4 DNA ligase (Biolabs, New
England) and restriction enzymes (Biolabs, New England) were
used according to the supplier’s recommendations. Purification
of the PCR products was performed using the High pure
PCR product purification kit from Roche or alternatively, the
QIAquick PCR purification kit from Qiagen. Purified PCR
products or recombinant plasmids were introduced into S.
pneumoniae by transformation as described in Kloosterman et al.
(2006a). Positive transformants were selected in M17 blood agar
or Brain Heart Infusion (BHI) agar containing 0.5% glucose
with the appropriate antibiotic and confirmed by PCR and
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TABLE 1 | Bacterial strains and plasmids used in this work.
Strains Description Source/References
S. pneumoniae
D39 Serotype 2 strain Lanie et al., 2007
D39SM Spontaneous mutant derived from serotype 2 strain D39 with characteristics of
underproducing capsule. Colony phenotype on plate: small and transparent.
This work
D39PcpsT→C D39 containing a point mutation (T→C, 30 nucleotides upstream of the starting codon (ATG) of
the cps2A gene) in the −10 region of the cps promoter (Pcps)
This work
D39carAC→A D39 containing a point mutation (C→A, at position 710-bp of the carA gene) This work
D39nisRK D39 1bgaA::nisRK; TrimR Kloosterman et al., 2006a
D39carAC→AnisRK D39 carAC→A 1bgaA::nisRK; Trim
R This work
D39 carAC→AnisRK pNZ[carA] D39 carAC→A 1bgaA::nisRK harboring pNZ[carA]; Trim
R, CmR This work
D39 carAC→AnisRK pNZ8048 D39 carAC→A 1bgaA::nisRK harboring pNZ8048; Trim
R, CmR This work
D39pPP2[PcpsT→C] D39 1bgaA::PcpsT→C-lacZ; Tet
R This work
D39pPP2[Pcps] D39 1bgaA::Pcps-lacZ; TetR This work
D39SMpPP2[PcpsT→C] D39SM 1bgaA::PcpsT→C-lacZ; Tet
R This work
D39SMpPP2[Pcps] D39SM 1bgaA::Pcps-lacZ; TetR This work
D39carAC→ApPP2[Pcps] D39carAC→A 1bgaA::Pcps-lacZ; Tet
R This work
E. coli
EC1000 MC1000 derivative carrying a single copy of the pWV01 repA gene in glgB; kmR Leenhouts et al., 1996
L. lactis
NZ9000 MG1363 1pepN::nisRK Kuipers et al., 1998
Plasmids
pPP2 Promoter-less lacZ. For replacement of bgaA with promoter-lacZ fusions. Derivative of pPP1;
AmpR, TetR.
Halfmann et al., 2007
pORI280 ori+ repA−, deletion derivative of pWV01; constitutive lacZ expression from P32 promoter;
EmR
Leenhouts et al., 1996
pNG8048e Nisin-inducible PnisA, pNZ8048 derivative containing EmR to facilitate cloning; CmR, EmR Kloosterman et al., 2006a
pNZ8048 Nisin-inducible PnisA; CmR Kloosterman et al., 2006a
pNZ[carA] pNG8048e carrying carA downstream of the nisA promoter; CmR This work
pORI[PcpsT→C] pORI280 carrying a 1,274-bp fragment, which contains a point mutation (T→C, 30 nucleotides
upstream of the starting codon (ATG) of the cps2A gene) in the −10 region of the cps promoter
(Pcps); EmR
This work
pORI[carAC→A ] pORI280 carrying a 1,213-bp fragment, which contains a point mutation (C→A), at position
710-bp of the carA gene; EmR
This work
pPP2[Pcps] pPP2 carrying a 1268-bp fragment, which contains the native cps promoter (Pcps), in front of
lacZ; TetR.
This work
pPP2[PcpsT→C] pPP2 carrying a 1268-bp fragment, which contains a point mutation (T→C, 30 nucleotides
upstream of the starting codon (ATG) of the cps2A gene) in the −10 region of the cps promoter
(Pcps), in front of lacZ; TetR
This work
sequencing. L. lactisNZ9000 was transformed with plasmid DNA
by electroporation as described before (Carvalho et al., 2011).
Sequencing of the dexB-cps2A Genomic
Region and Whole-Genome Sequencing
Analysis
The genomic region comprising 1,453-bp before and 396-bp after
the starting codon (ATG) of the cps2A gene was PCR amplified
with primers P1_capsule to P5_capsule and sent for sequencing
(Service XS, Leiden, The Netherlands). Streptococcus pneumoniae
gDNA extracted according to the procedure of Johansen and
Kibenich (1992) (Johansen and Kibenich, 1992) was sent for
sequencing to the Genome Analysis Facility, Dept. of Genetics,
University Medical Centre Groningen, The Netherlands.
Construction of the Pcps and carAMutants
The oligonucleotide primers used in this study are listed in
Table S8. Thymine, located 30 nucleotides upstream of the
initiation codon (ATG) of the cps2A gene, was replaced in
the TATAAT binding box of the cps locus with a cytosine,
thereby leading to TATAAC (Figure 2A), as follows. Up- and
downstream DNA fragments of 654- and 635-bp, respectively,
comprising the desired mutation were obtained by PCR
amplification with the primer pairs Pcapsule-1/Pcapsule-mut2
and Pcapsule-2/ Pcapsule-mut1, using D39 wild-type DNA as
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a template. The internal primers, Pcapsule-mut2 and Pcapsule-
mut1, comprise the point mutation leading to the TATAA
(T→C) change. The resulting PCR products were fused by
means of overlap extension PCR (Song et al., 2005) using the
primers Pcapsule-1 and Pcapsule-2, leading to the formation
of a DNA fragment (1,284-bp) containing the altered −10
binding box (TATAAC). This fragment was cloned into the
EcoRI/BamHI sites of pORI280, forming the pORI[PcpsT→C]
construct. Escherichia coli EC1000 was used as cloning host. This
construct was used to introduce the point mutation in the −10
promoter region of the cps locus of the chromosome of strain D39
following the procedure described previously by Kloosterman
et al. (2006a). The resulting strain was designated D39PcpsT→C.
The point mutation in carA was constructed by applying
the same method as for Pcps. In brief, the primers pairs carA-
1/carA-mut2 and carA-2/carA-mut1 were used to obtain up-
and downstream fragments of 634- and 618-bp, respectively,
by PCR amplification. These fragments, containing the desired
mutation (C→A at position 710-bp of the carA gene), were fused
and cloned into the EcoRI/BamHI sites of pORI280 in E. coli
EC1000, yielding pORI[carAC→A]. The carA point mutation in
D39 (carAC→A) was obtained as in Kloosterman et al. (2006a).
Construction of the carA Complementation
Strain
The carA complementation strain was constructed in S.
pneumoniae using the NICE system described before (Carvalho
et al., 2011). The carA mutant strain (D39carAC→A) was
transformed with D39nisRK chromosomal DNA, which contains
the nisRK genes and a TrimR gene in the bgaA locus. Clones
resistant to trimethoprim (D39carAC→AnisRK, Table 1) were
selected and the presence of the carA mutation was confirmed
by sequencing (STAB VIDA). The plasmid harboring carA under
the control of the nisin-indusible promoter nisA (pNZ[carA],
Table 1) was constructed as follows. The carA gene was PCR-
amplified from D39 gDNA using the primer pair carA_fw
and carA_rev and cloned as a BspHI/XbaI fragment into
NcoI/XbaI digested pNG8048e. L. lactis NZ9000 was used as
the cloning host. D39carAC→AnisRK strain was transformed
with pNZ[carA] and the empty plasmid pNZ8048. Transformed
strains were selected for chloramphenicol resistant clones and
confirmed by PCR.
Construction of Ectopic Pcps-LacZ and
PcpsT→C-LacZ Fusions
An ectopic transcriptional fusion of the capsule locus promoter
(Pcps) with the lacZ reporter gene was constructed using
the pPP2 plasmid (Halfmann et al., 2007). A DNA fragment
comprising Pcps was PCR-amplified from D39 chromosomal
DNA using the primer pair Pcapsule-1/Pcapsule-2. This
fragment (1284-bp) was cloned into the EcoRI/BamHI sites of
pPP2 and the resulting plasmid (pPP2[Pcps]) was integrated
via double cross-over into the bgaA locus of strains D39,
D39SM, and D39carAC→A, yielding strains D39pPP2[Pcps],
D39SMpPP2[Pcps] and D39carAC→ApPP2[Pcps], respectively.
To construct a lacZ fusion with the mutated cps locus promoter
(PcpsT→C), the PCR fragment containing PcpsT→C, generated as
described above, was cloned into the EcoRI/BamHI sites of pPP2.
The resulting plasmid (pPP2[PcpsT→C]) was integrated via a
double cross-over event into the bgaA locus of strains D39 and
D39SM, leading to the formation of strains D39pPP2[PcpsT→C]
and D39SMpPP2[PcpsT→C], respectively.
β-Galactosidase Activity Measurements
Cells containing the promoter-lacZ fusions were grown in CDM
containing 1% glucose, with or without uracil, as described above.
Culture samples of 2mL were harvested during mid-exponential
phases of growth and the activity of the promoters was assayed
by measuring β-galactosidase activities as described before by
Kloosterman et al. (2006a).
Transcriptome Analysis
Strains D39SM and D39PcpsT→C were compared to S.
pneumoniae D39 by transcriptome analysis using whole-
genome S. pneumoniae DNA microarrays, representing all
TIGR4 open reading frames (ORFs), as well as R6 and D39 ORFs
that are not in TIGR4 (Kloosterman et al., 2006b). Each strain
was grown in triplicate in CDM containing 1% glucose and with
or without uracil as described above. Cells for RNA isolation
were harvested in mid-exponential phase of growth (Figure 1B).
mRNA isolation, synthesis of cDNA and labeling of cDNA was
performed as described in Carvalho et al. (2011). All samples
were hybridized in duplicate in the spotted DNA microarrays.
Scanning of the slides and the processing and analysis of the
data was carried out as described before (Carvalho et al., 2011).
Genes were considered to have significantly altered expression
when the bayesian p-value was <0.0001 and the ratio (signal
D39SM /signal D39 or signal D39PcpsT→C /signal D39) was >3
and <-3. An in silico comparison was done between conditions
with and without uracil in both D39 wild-type as well as D39SM.
To this end, raw signals (i.e., slide images) of the experiments
with uracil were compared with the corresponding signals of
the experiments without uracil and analyzed as described above.
The microarray data is deposited in GEO under the accession
number GSE109129.
Quantification of the Glucuronic Acid
Content of Capsular Polysaccharide
Samples for the determination of the capsular glucuronic acid
amounts were grown in CDM supplemented with 1% glucose,
with or without uracil, as described above, harvested during
mid-exponential phases of growth (Figure 1B) and treated as in
(Carvalho et al., 2011). In brief, cells were centrifuged (6,000 x g,
3-7min, 4◦C), resuspended in PBS and pelleted at 3000 x g, 4◦C,
for 20min. The pellet was resuspended in 500 µL of 150mM
Tris-HCl (pH 7.0) and 1mM MgSO4 and treated as described
elsewhere (Morona et al., 2006). The supernatants were treated
with 20% (wt/vol) trichloroacetic acid for protein precipitation
and cold ethanol for exopolysaccharide precipitation as in Ramos
et al. (Ramos et al., 2001). The glucuronic acid of capsule
was quantified by the method for quantitative determination of
uronic acids as described by Blumenkrantz and Asboe-Hansen
(1973).
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FIGURE 1 | Colony phenotype, growth profile, and capsule production in D39 and its derivatives. (A) Colony phenotype of D39, D39SM, and R6 strains in Glc-M17
blood agar plates. (B) Growth profiles of strains D39 (squares), D39SM (diamonds), D39PcpsT→C (circles) and R6 (triangles) in Glc-CDM (closed symbols) and
Glc-CDM without uracil (open symbols), at 37◦C, without pH control (initial pH 6.5), in static rubber-stoppered bottles. The growth rates (h−1) for each strain are
indicated in the graph and the values shown are means from three biological replicates ± SD. (C) Estimation of capsule was performed based on the determination of
its glucuronic acid content in D39 and its derivatives grown in Glc-CDM (black bars) and Glc-CDM lacking uracil (white bars), at mid-exponential phases of growth.
Capsule measurements were performed in duplicate using samples from two independent cultures and the values represented are means ± SD.
***p-value = 0.0002.
Determination of UTP Levels
Streptococcus pneumoniae was grown in CDM with or without
uracil, as described above, and cells were harvested at
mid-exponential phase of growth for the determination of
intracellular UTP. The UTP content was measured by one-
dimensional thin-layer chromatography (TLC) as described in
Jendresen et al. (2011).
Statistics
The statistical analyses (p-values) were obtained by using the
two tailed unpaired student’s t-test of GraphPad Prism software
(GraphPad version 5.01, San Diego, CA), with a confidence
interval of 95%. Data is presented as mean ± standard deviation
(SD).
RESULTS
Isolation of a D39 Spontaneous Mutant
With Non-Producing Capsule Phenotype
Unexpectedly, streaking a single GM17 liquid grown working
stock, which was started from a −80◦C stock of D39, on
GM17-agar plates resulted in the appearance of two colony
phenotypes. One colony type displayed the typical characteristics
of the D39 Lilly isolate (Lanie et al., 2007), i.e., large and opaque
colonies. The other colony type, hereafter denominated D39SM
(D39 spontaneous mutant), exhibited a substantially smaller
colony size and higher transparency than D39 (Figure 1A,
Image S1). A single colony isolate of both the typical D39 Lilly
phenotypic strain and the phenotypic variant was selected for
further characterization. Individual growth and restreaking of
the two isolates, D39 and D39SM, in GM17 liquid medium and
agar plates always gave rise to colonies exhibiting their parental
phenotype. The phenotype of D39SM colonies, resembling
that of strain R6 (Figure 1A, Image S1), could be due to
a considerably lower growth rate or to a decreased capsule
production (Kim et al., 1999; Carvalho, 2012). Both wild-type
and D39SM strains were grown in CDM containing 1% glucose,
as described in Material and Methods, and the amount of
capsule was determined in the mid-exponential phase of growth
(D39, OD600 of 0.40 ± 0.00; D39SM, OD600 of 0.48 ± 0.02;
Figure 1B). The maximal growth rate of strain D39SM was
1.4-fold lower than that of strain D39 (Figure 1B). Interestingly,
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FIGURE 2 | Expression of Pcps and PcpsT→C in D39 and D39SM. (A) Schematic overview of the dexB-cps2A region and magnification of the cps promoter area of
D39SM. Hooked arrow, cps promoter; lollipop, putative terminator; zoomed area (inset), promoter region of the cps gene cluster; −35 and −10 binding box, and the
starting codon of the cps2A gene are indicated in bold; the number of bp of the cps2A gene next to the starting codon is subscripted after {n}; *, point mutation
(T→C) in −10 binding box of D39SM strain. (B) Transcription of cps and cpsT→C promoters was estimated by measuring β-galactosidase activities in exponentially
growing D39 and D39SM strains, carrying the pPP2 integrative lacZ reporter plasmid, in Glc-CDM (black bars) and Glc-CDM depleted of uracil (white bars).
β-galactosidase activities are expressed as Miller units. (C) Colony phenotype of D39SM and D39PcpsT→C strains in Glc-M17 blood agar plates. All the
determinations were done in duplicate in two independent experiments and the values represented are means ± SD. *p-value < 0.05.
this decrease in the growth rate is in contrast with the 1.4-fold
increase in the final biomass reached by D39SM strain relative
to the parent strain (Figure 1B). Moreover, the amount of
capsule in D39SM was 12.4-fold lower relative to D39 levels
(unpaired t-test, p-value < 0.0001; Figure 1C). Considering
these data, the small colony and high transparency phenotype
most likely reflects the substantial reduction in capsule amount,
rather than the slight decrease in growth rate. Interestingly,
the amounts of glucuronic acid in D39SM were similar to
those of R6, the non-encapsulated derivative of strain D39,
showing that D39SM is also nearly or entirely devoid of capsule
(Figure 1C). Further analysis of the original culture from which
D39SM was isolated revealed a frequency of D39SM colonies
approximately 100-fold lower than that of the wild-type colonies.
Moreover, the growth profile of other D39SM siblings isolated
from the original culture was similar to that of D39SM that
we selected for further characterization (data not shown). The
scarce number of mutant colonies suggests that their appearance
was an exceptional event that occurred exclusively during the
preparation of this working stock. Supporting this notion, the
only phenotype recovered upon growth of any other of our
working stocks in Glc-M17 agar was that of the progenitor D39
strain.
Whole-Genome Sequencing Analysis of a
D39 Spontaneous Mutant Lacking the
Capsular Polysaccharide
The appearance of a D39 spontaneous mutant, phenotypically
similar (acapsular) to strain R6, without inflicted selection
pressure or artificial manipulation, during an overnight growth
on GM17, prompted us to understand the origin of D39SM.
We envisaged two possible scenarios: (i) unknown factor(s)
drove natural selection pressure on D39 causing spontaneous
mutation(s) on this strain; (ii) a contamination of the D39
GM17 culture with strain R6, used routinely in our laboratory,
led to extensive genome recombination between both strains.
Extensive genome recombination between two bacterial strains
generally results in recombination phenomena, such as DNA
duplication and deletion, and in chromosomal rearrangements,
namely DNA inversion. Thus, we performed whole-genome
sequencing analysis of one single colony of strains D39SM and
D39 to gain better insight into the origin of D39SM.
The whole-genome sequencing analysis revealed that D39SM
genome contains 105 mutations relative to the genome of D39
(Tables S1, S2). Moreover, 80% of the mutations in D39SM are
non-synonymous, nonsense and frameshifts, thus altering amino
acid sequences of protein products. Strikingly, ∼60% of D39SM
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mutations match those observed for the non-encapsulated strain
R6 (Table S2), including mutations in the genes encoding
functions of the de novo synthesis of pyrimidines, namely
carA, carB and pyrDa, previously linked to capsule production
(Carvalho, 2012; Carvalho et al., 2013b), and one point mutation
in the capsule locus promoter (Pcps). However, the first nine
genes of the capsule cluster (cps2ABCDETFGH) of D39SM
are completely intact, while in strain R6 cps2BCDETFG and
cps2A/cps2H genes are fully and partially deleted, respectively
(Iannelli et al., 1999), which indicates that: (i) the acapsular
phenotype of D39SM is not caused by deletion(s) within the cps
locus or point-mutations in the cps operon, particularly in the
initial five genes cps2A-E (Yother, 2011; Schaffner et al., 2014;
Shainheit et al., 2015; Wen et al., 2016) and (ii) D39SM is not
strain R6. Moreover, about 87% of D39SM mutations are single-
nucleotide polymorphisms (SNPs), while duplicated and inverted
DNA is absent and only a few DNA deletions were detected
(Table S2). Thus, most likely an unknown factor imposing
selection pressure on D39 led to the appearance of D39SM rather
than an overnight extensive recombination between strains R6
and D39. In fact, many other mutations (40%) of D39SM,
presumably required for its proper functioning, are not present
in strain R6.
A Point Mutation in D39 Pcps Locus Leads
to Decreased Capsule Production
As revealed by whole-genome sequencing analysis, D39SM
presents an intact cps operon, thus we hypothesized that
the diminished capsule production in this strain could be
due to a point mutation in the promoter region of the
capsule cluster (Pcps) (Moscoso and García, 2009; Yother,
2011; Schaffner et al., 2014; Shainheit et al., 2015; Wen et al.,
2016). A correlation between decreased cps expression and
polymorphisms in the promoter of the cps gene cluster in
S. pneumoniae is not unprecedented (Moscoso and García,
2009; Yother, 2011). The whole-genome sequencing analysis
revealed a single point mutation in the −10 promoter region
localized 30 nucleotides upstream of the starting codon of
cps2A, and leading to the transition of the consensus sequence
TATAAT to TATAAC (PcpsT→C) (Figure 2A), which was further
validated by sequencing of the dexB-cps2A genomic region.
Interestingly, the same base substitution is present in the Pcps
of the non-encapsulated D39 derivative strain R6 (Hoskins
et al., 2001; Moscoso and García, 2009). In addition, considering
that strain R6 harbors a large deletion (7.5 kbp) in the cps
locus, most likely the events leading to the arising of the
two strains were distinct. To investigate whether the decreased
capsule production was mediated at the transcriptional level by
PcpsT→C mutation, the activity of cps and cpsT→C promoters
was measured. Fusions of these promoters with the lacZ reporter
gene were generated in the pPP2 plasmid (Halfmann et al.,
2007) and introduced into D39 and D39SM backgrounds. The
D39pPP2[Pcps], D39pPP2[PcpsT→C], D39SMpPP2[Pcps] and
D39SMpPP2[PcpsT→C] strains generated in this way were grown
in CDM containing 1% glucose, harvested in exponential phase
and β-galactosidase activities were determined. The activity of
the cpsT→C promoter was decreased by 18-fold relative to the
activity of the Pcps in D39 and D39SM strains (unpaired t-test,
p-value = 0.001 and 0.0008, respectively) (Figure 2B). Even
though data are only shown for mid-exponential phase of growth
(Figure 2B), low promoter activity was observed throughout
growth (data not shown). This suggests that the reduction in
capsule production is caused solely by the PcpsT→C mutation.
To strengthen our hypothesis, the PcpsT→C point mutation was
generated in the chromosome of strainD39 by using the pORI280
plasmid as described in section Materials and Methods. The
amount of capsule in the D39PcpsT→C mutant, as estimated
from the GlcUA method, was similar to that in D39SM and 8-
fold lower than that of the parent strain D39 (unpaired t-test,
p-value = 0.0001; Figure 1C). Furthermore, in Glc-M17 blood
agar plates the morphology of D39PcpsT→C colonies totally
resembled that of D39SM (Figure 2C, Image S2). These data
provide evidence that the PcpsT→C mutation is responsible for
reduction of capsule synthesis. The additional mutations in
D39SM are responsible for its lower maximal growth rate and
final biomass when compared to those of strain D39PcpsT→C
(Figure 1B), and the non-production of capsule is responsible for
the higher biomass of D39PcpsT→C and D39SM relative to D39,
consistent with capsule being an energetic burden (Hathaway
et al., 2012) (Figure 1B).
Genomic Changes in Strain D39SM
Influence Greatly the Transcriptome
The effects of D39SM mutations and the Pcps mutation in
D39 were analyzed by whole-genome transcriptome analysis
comparing mRNA levels in the mutant strains to those
in strain D39. The total number of genes that showed
significant altered expression in D39PcpsT→C versus D39
microarray, according to the cut-off criteria applied, was 5.8-
fold lower than that observed for D39SM versus D39 microarray
(Tables S3, S4), which confirms a major influence of the
mutations other than PcpsT→C in the D39SM phenotype. As
expected from our targeted analysis, the cps genes (spd_315-18,
spd_321-2) were strongly downregulated in both mutant
strains (Tables S3, S4). In D39PcpsT→C the transcriptional
response was modest and besides capsule repression, the most
significant alterations were the upregulation of the spd_0277-83
operon, coding for a 6-phospho-beta-glucosidase, a lactose-type
phosphoenolpryruvate:carbohydrate phosphotransferase system
(PTS)- transporter and a multi-domain transcriptional regulator,
presumably involved in the transport of beta-glucosides (Bidossi
et al., 2012), and the downregulation of three hypothetical
proteins (spd_0486, spd_2001, spd_2038) and of the spd_1514-6
operon, which includes an ATP-binding cassette (ABC)-
transporter and two hypothetical proteins (Table S4). The
transcriptional response of strain D39SM affected circa 5%
of the whole genome, i.e., 100 genes. Most of the genes (35
genes) showing altered expression belonged to the carbohydrate
transport and metabolism category. In addition, many genes
with unknown (7 genes) or unpredicted (21 genes) function,
as well as a number of genes (9 genes) with general function
prediction only, were among the differentially expressed genes
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(Table S3). Noteworthy, eight PTS uptake systems (spd_0066-
9, spd_0502, spd_0559-61, spd_0661, spd_1047-8, spd_1057,
spd_1959, and spd_1992-89), and the enzymes involved in the
metabolism of the PTS-incoming sugars (spd_0063, spd_0065,
spd_0070-1, spd_0503, spd_0562, spd_1046, spd_1958-7, and
spd_1995-4) were all strongly induced in the mutant strain
(Table S3). The spd_0277-83 operon induced in the D39PcpsT→C
mutant was, however, not among the upregulated genes in
strain D39SM. The PTS transporters upregulated in D39SM
are hypothetically involved in the uptake of sugars (galactose,
beta-glucosides, lactose, galactitol, maltose, tagatose, fucose, L-
arabinose) other than glucose (Table S3) (Bidossi et al., 2012).
RegR, another global regulator of the family LacI/LacR, involved
in carbohydrate metabolism, was upregulated in D39SM. In
addition to the PTS transporters, the catabolic enzymes, and
RegR, the altered expression of two other genes called our
attention in strain D39SM. The first gene (spd_0267) encodes
a permease that putatively transports xanthine/uracil and the
second gene encodes a putative dihydroorotase (pyrC, spd_1030),
which is known in other species to dehydrate carbamoyl aspartate
(CAA) forming dihydroorotate (DHO) in the de novo pathway
for pyrimidine synthesis (Kilstrup et al., 2005). pyrC is part
of a transcriptional unit comprising two other genes, ung and
mutT, also induced in the mutant strain, and encoding functions
unrelated to the de novo synthesis of pyrimidines (Table S3).
Dihydroorotate is an early precursor for the synthesis of UMP,
which is subsequently converted to UTP via the salvage pathway
for pyrimidine biosynthesis (Kilstrup et al., 2005). We have
previously shown that growth of S. pneumoniae D39 is limited
by the nucleobase uracil (Carvalho, 2012; Carvalho et al., 2013b).
Since the un-encapsulated strain R6 was rather insensitive to
uracil and only marginally affected when the nucleobase was
omitted from the cultivation medium, we speculated that the
effects on D39 were related to capsule synthesis, a process
that consumes UTP (Carvalho, 2012; Carvalho et al., 2013b).
In this context, the differential regulation of genes involved
in the pyrimidine biosynthetic pathways, a putative uracil
transporter and pyrC (Table S3), in D39SM, a strain impaired
in capsule synthesis and mutated in the de novo synthesis of
pyrimidines genes carA, carB and pyrDa, when uracil was present
in the medium was intriguing. Furthermore, repression of the
xanthine/uracil permease gene or induction of the pyrC gene was
not observed in the D39PcpsT→C strain (Table S4), which is also
deficient in capsule production.
The mutations and altered expression of genes involved
in pyrimidine biosynthetic pathways further reinforces the
assumption of a tight connection between uracil metabolism and
capsule production.
D39 Mutants Impaired in Capsule
Production Are Largely Unresponsive to
the Presence of Uracil
Strains D39SM and D39PcpsT→C are “quasi” or non-
encapsulated (Figure 1C), and consequently should have a
lower requirement for uracil/UTP, as shown for strain R6
(Carvalho, 2012; Carvalho et al., 2013b). The influence of uracil
on capsule production was evaluated by cultivating strains D39,
D39SM and D39PcpsT→C in the absence of the nucleobase
and comparing with the results obtained in complete medium.
In the absence of uracil, strains D39SM and D39PcpsT→C
presented growth profiles and capsule amounts similar to those
in medium with uracil (Figures 1B,C). In contrast, strain D39
was profoundly affected by the omission of uracil: growth was
characterized by a lag of about 6 h, a growth rate of 0.42 ±
0.01 h−1, 2-fold lower than in medium containing uracil, and a
maximal biomass 1.8 ± 0.0, which represented a 20% increase
as compared to the standard conditions (uracil 10mg L−1)
(Figure 1B). Furthermore, strain D39 exhibited a significant
22% decrease (unpaired t-test, p-value = 0.0002) in capsule
amount relative to that produced in medium containing uracil
(Figure 1C). Our data show a subtle coupling between uracil
metabolism, capsule production and growth of strain D39.
In agreement, the growth dependency on uracil is lost in
un-encapsulated strains.
Uracil Affects the Transcriptome of Strain
D39
To gain further insight into the effect of uracil in S. pneumoniae,
we grew strains D39SM and D39 in medium lacking uracil as
in Figure 1B, and harvested samples at mid-exponential phase
for transcriptome analysis (Figure 1B). In the absence of uracil,
the D39SM versus D39 transcriptional response affected 4.2% of
the whole genome (2069 genes). Of the genes showing altered
transcript levels, 87%were common inmediumwith and without
uracil (Tables S3, S5). An in silico DNA microarray analysis
comparing D39 grown in CDM with and without uracil revealed
a strong derepression of genes involved in de novo synthesis of
pyrimidines [spd_0608-9 (pyrFE) and spd_0851-2 (pyrKDb)] in
the absence of uracil (Table S6). Consistent with activation of the
genes of the de novo synthesis of pyrimidines, the gene encoding
a putative PyrR regulatory protein (spd_1134), an homolog of
the lactococcal PyrR protein known to activate the expression
of pyrimidine biosynthetic genes (Kilstrup et al., 2005), was also
upregulated in S. pneumoniae strainD39when uracil was omitted
(Table S6). Our in silico data are in good agreement with the
accepted view for other Streptococcaceae (Kilstrup et al., 2005).
The in silico DNA microarray analysis comparing D39SM
grown in CDM with and without uracil showed no significant
altered expression of genes (a cut-off of >3 or <-3 was used
for the fold change and a Bayesian p-value ≤ 0.0001 to consider
fold change statistically significant). Similarly, the absence of
uracil did not induce major changes in the transcriptome
profile of strain D39PcpsT→C when compared with its parent
strain D39, exceptions being the operon spd_1514-6 and gene
spd_0109 (Tables S4, S7). Overall, these results show that uracil
(or pyrimidines) has no major effect on the transcriptome of
strains D39SM and D39PcpsT→C, while inducing a considerable
transcriptional response in the capsulated strain D39.
The Activity of the Cps Promoter Is Lower
in the Absence of Uracil
In strain D39 the amounts of capsule decreased in medium
lacking uracil. To investigate whether this effect was mediated
at the transcriptional level we measured the activity of the
native and mutated cps promoters in cells grown without uracil
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(Figure 2B). Interestingly, in the absence of uracil the activity of
the native cps promoter measured in D39 cells collected at mid-
exponential phase was 25% lower than in D39 grown in medium
with uracil (Figure 2B), a decrease similar to that observed
for the reduction of capsule in strain D39 in uracil depleted
conditions (Figure 1C). As expected, uracil had no effect on the
activity of the cpsT→C promoter, independently of the genetic
background (Figure 2B). Thus, the observed reduction in capsule
production is presumably controlled at the transcriptional level
through modulation of the cps promoter activity by uracil or an
intracellular derivative, such as UMP or UTP. In the capsulated
strain D39, the UTP pool was higher in medium containing
uracil (data not shown). The same pattern was observed for strain
D39SM (data not shown), but since this variant produced little or
no capsule, its requirements for UTP are lower, and thus growth
is not affected.
carA Mutation Decreases Pcps Expression
in Medium Without Uracil
Our data provide evidences for a link between uracil/pyrimidine
metabolism and capsule synthesis. Furthermore, we show that
a spontaneous mutant with non-producing capsule phenotype
contains several mutations in genes of the de novo synthesis
of pyrimidines, namely carA, carB, and pyrDa. To show the
link between pyrimidine metabolism and capsule production
we measured capsule promoter expression in mid-log grown
cells of strain D39 mutated in one of the genes that code for
the enzymes of the de novo synthesis of pyrimidines found
to be mutated in the spontaneous mutant. The gene selected
was carA, that codes the small subunit of carbamoyl-phosphate
synthase, the first enzyme of the de novo synthesis of pyrimidines
pathway, that in D39SM contains an adenine instead of a
cytosine localized 707 nucleotides downstream the starting
codon, thereby leading to the translation of a valine instead
of a glycine. This point mutation found in the D39SM strain
was constructed in D39 background leading to the formation of
D39carAC→A. Remarkably, carA mutation led to a significant 2-
fold decrease in capsule promoter expression in comparison with
the wild-type strain, during the exponential phase in medium
without uracil (Figure 3). In contrast, in medium containing
increasing concentrations of uracil, such as 5 and 10mg L−1,
no significant differences in capsule promoter expression were
observed between the wild-type and the carAmutant (Figure 3),
which is consistent with the presence of uracil in the medium and
thus with activation of the salvage pathways for the production of
UMP/UTP. Surprisingly, as for strains D39SM and D39PcpsT→C,
the growth profile of the carA mutant revealed to be insensitive
to the presence of uracil (Figure S1), suggesting that somehow
the de novo synthesis of pyrimidines was already induced in the
mutant strain. Importantly, growth of the D39carAC→A mutant
with expression in trans of carA under the control of the nisin
promoter, resembled that of D39 in medium devoid of uracil
(Figure S1). It should be noted that the growth profile of D39
carAC→AnisRKpNZ8048 was similar to that of the D39carAC→A
mutant (data not shown).
FIGURE 3 | Capsule promoter expression in D39 carA mutant exposed to
different amounts of uracil. Transcription of Pcps was estimated by measuring
β-galactosidase activities in exponentially growing carA mutant and wild-type
strains, carrying the pPP2 integrative lacZ reporter plasmid, in Glc-CDM with 0
(0U), 5 (5U), and 10 (10U) mg L−1 uracil. β-galactosidase activities are
expressed as Miller units. The values represent the means of the Pcps
expression ratios ± SD obtained from two biological independent samples
assayed in duplicate. **p-value = 0.0025.
In Uracil-Free Medium D39SM Performs
Better Than the Parent D39
Bacterial spontaneous mutations generally occur during
adaptation to a stressful environment. In this context, it is
likely that loss of the ability to produce capsule conferred the
resulting phenotype with a competitive advantage. Considering
the established interplay between uracil metabolism and capsule
production we surmised that the mutant strain would perform
better in uracil-devoid environments. To verify our hypothesis
D39SM and its parent D39 were grown in co-cultivation in
medium with and without uracil (Figure 4). Strain abundance
in the co-cultures was assessed by the CFU counts of samples
harvested in mid-exponential phase of growth (Table 2;
Figure S2). In medium containing uracil, in mid-exponential
growth the most abundant species was the one predominating
at the time of inoculation (Table 2; Figures S2A,B, Images
S3–S8). Moreover, the dominant strain in the co-culture
dictated to a great extent the growth profile of the mixture
(Figure 4A). Curiously, a D39:D39SM ratio of 1 at the beginning
of growth resulted in a very slight prevalence of strain D39 at
mid-exponential phase (ratio D39:D39SM of 1.34, Table 2);
the growth rate of the co-culture was more similar to that of
D39, but the maximal biomass reached values similar to those
achieved by D39SM (Figure 4A; Figures S2A,B, Images S3–S8).
A possible explanation resides on the ability of D39SM to grow
well in the absence uracil, which at 10mg L−1 is limiting for
strain D39. Notably, in uracil-free medium at mid-exponential
growth strain D39SM prevailed over D39, independently of
the inoculation ratio (Table 2; Figures S2C,D, Images S9–S14).
The predominance of strain D39SM in uracil-deprived medium
resulted in maximal biomass of about 2.1 (ODMax) in the
different co-cultures, values similar to those reached by strain
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TABLE 2 | D39 to D39SM ratios of viable cell counts (CFU mL−1 ) in co-culture at the time of inoculation (T_0) and in mid-exponential phase of growth (T_MExp).
D39:D39SM ratio Uracil (+U) No uracil (-U)
T_0 0.94 ± 0.19 0.28 ± 0.04 4.09 ± 0.38 0.99 ± 0.42 0.23 ± 0.03 2.83 ± 0.25
(1/1) (1/4) (4/1) (1/1) (1/4) (3/1)
T_MExp 1.34 ± 0.45 0.43 ± 0.11 4.87 ± 0.39 0.09 ± 0.02 0.04 ± 0.01 0.40 ± 0.12
(1/1) (1/2) (5/1) (1/11) (1/25) (1/3)
Co-cultures of D39 wild-type and D39SM were grown as in Figure 4 and plated as in Figure S2.
FIGURE 4 | Growth profiles of strains D39 wild-type and D39SM in co-cultivation. D39 and D39SM strains were inoculated at a cell ratio of 1:1 (), 1:4 (N), and 4:1
(•) in (A) CDM or (B) CDM without uracil, containing 1% Glc, and grown at 37◦C, without pH control (initial pH 6.5), in static rubber-stoppered bottles. The growth
rates of the co-cultures are presented in the graphs. The values are averages from three independent cultures ± SD. For comparison the growth curves and growth
rates of monocultures of D39 () and D39SM () are also shown. +U, with uracil; -U, without uracil.
D39SM alone (Figure 4B). In uracil-free medium, the average
growth rate of the co-cultures also reflected the predominance of
strain D39SM (Figure 4).
Our data show that D39SM presents competitive fitness over
strain D39 in uracil-free conditions. This advantage most likely
derives from the low requirement of the mutant strain for uracil
due to impairment in capsule production. In conclusion, our
data indicate that in uracil poor media capsule production is a
tremendous nutritional burden.
DISCUSSION
Capsule is the major virulence factor of S. pneumoniae, and
conditions affecting its synthesis are of great interest for the
scientific community. However, the underlying molecular
mechanisms controlling capsule production remain at large
unknown (Weiser et al., 2001; Hammerschmidt et al., 2005;
Carvalho, 2012). Previously, we proposed a link between
pyrimidine metabolism and capsule biosynthesis in S.
pneumoniae D39 (Carvalho, 2012; Carvalho et al., 2013b).
In this work, we show that uracil affects capsule promoter
expression and capsule production in S. pneumoniae strain D39.
Uracil is a pyrimidine nucleobase involved in the production
of sugar-precursors for the synthesis of exopolysaccharides and
peptidoglycan in lactic acid bacteria (Kilstrup et al., 2005). In
S. pneumoniae strain D39, formation of the activated sugar
precursors, UDP-Glc, UDP-GlcUA, and dTDP-Rha, for capsule
production, requires the pyrimidine nucleotides, UTP and
dTTP. Generally, UTP is synthesized via the salvage pathway
for pyrimidine biosynthesis, but it can as well be synthesized
de novo from glutamine, aspartate and CO2 (Figure 5). The
routes for pyrimidine biosynthesis in this bacterium are not
biochemically characterized, but the complete salvage and
de novo pathways can be deduced from genome information
(http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi) and database
surveys (KEGG, MetaCyc) (Figure 5). Moreover, transporters
for uracil are predicted in the genome sequence of strain D39
(Lanie et al., 2007). In light of our results we propose that in S.
pneumoniae strain D39 the operative pathway for pyrimidine
biosynthesis in uracil-containing media is the salvage, whereas
in the absence of uracil the de novo route is activated (Figure 5).
In agreement is the long lag phase displayed by D39 in medium
devoid of uracil that most likely reflects the time required
for significant expression of the genes of de novo synthesis of
pyrimidines (Figure 5). This idea is further corroborated by
the presence of intact de novo pathway genes (Table S1) and
the strong induction of these genes in medium without uracil.
Induction of the pathways of de novo synthesis of pyrimidines
in the absence of pyrimidines is not unprecedented (Kilstrup
et al., 2005; Turnbough and Switzer, 2008). The lower growth
rate observed for strain D39 in uracil-free medium could
derive from a less efficient de novo pyrimidine production.
We also hypothesized that capsule expression of strain D39
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is influenced by the levels of intracellular pyrimidine(s). In
good agreement with this assumption are: (i) the lower UTP
and capsule amounts in strain D39 in the absence of uracil,
and (ii) the potentially lower capsule promoter expression in
medium lacking uracil of the D39 mutant strain containing
a non-synonymous single-nucleotide mutation in carA. The
product of the latter catalyzes the initial step of de novo
synthesis of pyrimidines (Figure 5). Limitation of the de novo
pyrimidine pathway by its own substrates (aspartate, glutamine
and bicarbonate/CO2, Figure 5) cannot be ruled out, but is
improbable under our conditions: the initial concentrations of
aspartate and glutamine in the growth medium are relatively
high (circa 3mM), thus depletion is not expected. Furthermore,
the growth profile of strain D39 in CDM without uracil is not
affected by addition of bicarbonate up to 50mM (data not
shown). Altered synthesis of polysaccharides in response to
variation in pyrimidine concentrations is documented in the
literature. In E. coli, synthesis of the cellulose exopolysaccharide
changes in response to variation in pyrimidine availability
(Garavaglia et al., 2012). Interestingly, inactivation of genes
belonging to the de novo synthesis of UMP impairs cellulose
production, which can be triggered by addition of exogenous
uracil (Garavaglia et al., 2012). In Vibrio cholerae, pyrimidines
play an important role in the control of exopolysaccharide
production and biofilm formation, via the regulator CytR, which
represses nucleosides uptake and catabolism when these are
scarce (Haugo and Watnick, 2002). In Pseudomonas fluorescens,
a spontaneous mutation in a gene of the de novo synthesis
of pyrimidines, carB, affects the proportion of capsulated to
non-encapsulated subpopulations, by lowering the UTP cellular
concentrations and upregulating capsule (CAP) expression
(Beaumont et al., 2009; Gallie et al., 2015). In a S. thermophilus
galactose-fermenting mutant strain, displaying increased
activities of the Leloir genes, exopolysaccharide production was
enhanced by overexpressing galU, that codes for the enzyme
that converts α-glucose 1-phosphate (α-G1P) to UDP-Glc at the
expense of UTP (Levander et al., 2002). Deletions in galU lead
to a substantial decrease in capsule amounts, growth defects
and attenuation of virulence in S. pneumoniae (Mollerach et al.,
1998; Hardy et al., 2000, 2001). Hence, it is plausible that capsule
production in S. pneumoniae is affected by uracil, and ultimately,
by UMP/UTP availability (Figure 5). Intriguingly, while in S.
pneumoniae higher production of capsule is observed in the
presence of higher intracellular UTP levels, in Pseudomonas
fluorescens an increase in the pool of available UTP favors the
non-capsulated phenotype and biomass synthesis (Gallie et al.,
2015). The reason for the disparity between our results and
those observed for P. fluorescens may lie in the complexity of
regulatory systems sustaining central metabolism in different
microorganisms and conditions. In the absence of uracil, D39
produces less capsule, but more biomass (Figure 5). Even though
a full explanation cannot be put forward, we can speculate that
the coupling between uracil metabolism and capsule production
is somewhat lost in the absence of external uracil. Capsule was
indicated as an enormous energetic burden, and its production
was suggested to compete directly with central metabolism
for energy (Hathaway et al., 2012). In this light, in uracil-free
FIGURE 5 | Proposed model for the effect of uracil on pyrimidine metabolism,
biomass and capsule production in S. pneumoniae. The intracellular reactions
depicted are catalyzed by the following enzymes (the genes that code for the
enzymes are in parenthesis): carbamoyl-phosphate synthase, small and large
subunit (carAB), aspartate carbamoyltransferase (pyrB), dihydroorotase (pyrC),
dihydroorotate dehydrogenase A (pyrDa), dihydroorotate dehydrogenases
(pyrDb-pyrK), orotate phosphoribosyltransferase (pyrE), orotidine 5-phosphate
decarboxylase (pyrF ), uridylate kinase (pyrH), pyrimidine-nucleoside
phosphorylase (pdp), uridine kinase (udk), nucleoside-diphosphate kinase
(ndk). Narrower red and green arrows indicate the pathways active when uracil
is absent and present, respectively. Bold red and green arrows pointed up
indicate an increase in biomass and capsule expression in the absence or
presence of uracil, respectively, whereas pointed down arrows indicate a
decrease. Asp, aspartate; CAA, carbamoyl-aspartate; CP,
carbamoyl-phosphate; DHO, dihydroorotate; Gln, glutamine; Glu, glutamate;
HCO3− , bicarbonate; OMP, orotate monophosphate; Pi, inorganic phosphate;
U, uracil; UR, uridine. The nomenclature for the nucleotide abbreviations are
provided in the list of abbreviations of this manuscript.
medium the lower production of capsule is accompanied by a
lesser energy demand, and consequently the energy surplus can
be redirected for growth and cell division (Figure 5).
We have shown that a point mutation in the −10 box of the
cps promoter region is responsible for the remarkable decrease in
promoter activity leading to reduced capsule production in strain
D39. This point mutation was identified in the D39 spontaneous
mutant, D39SM, exhibiting phenotypic characteristics of a
non-capsulated variant. Unexpectedly, this mutant arose in
a rich/complex medium from D39 colonies. Even though a
chronology of the events leading to the mutant is available,
a mechanistic explanation for its appearance without selective
pressure or artificial manipulation is difficult to put forward. This
view is exacerbated by the considerable number of mutations
and transcriptional changes (about 5% of genome) in the mutant
when compared to its parent D39 and by D39SM similarity
with strain R6. Although we cannot undeniably rule out that
D39SM could result from extensive recombination between
strains D39 and R6, our own data does not support this
hypothesis. Specifically, D39SM possesses intact the first nine
genes of the capsule cluster, that are deleted in strain R6; D39SM
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contains a high number of mutations that are absent in strain
R6; the genome of D39SM does not present alterations resulting
from extensive recombination phenomena, namely duplicated
and inverted DNA. The desensitization to uracil of the mutant
strain and the differential expression of genes involved in its
metabolism could indicate a batch-specific deficiency of the
nucleobase in the M17 powder used. However, a deficiency
of other components, such as sugars, cannot be discarded. In
several Gram-positivemicroorganisms, including S. pneumoniae,
CcpA is a global regulator of carbon metabolism affecting
a high number of sugar transporters and catabolic enzymes
(Abranches et al., 2008; Carvalho et al., 2011; Carvalho, 2012).
A number of carbohydrate PTS transporters and associated
sugar catabolic enzymes were induced in the mutant strain
as compared to the parent D39 in the microarray analysis.
This observation may derive from a relief of CcpA-mediated
glucose repression on non-glucose transporter-encoding genes,
as ccpA nucleotide sequence contains a non-synonymous point
mutation that most likely affects CcpA function (Table S3;
Carvalho et al., 2011). On the other hand, the gene encoding
RegR, a regulator of the LacI/LacR, was strongly induced in
the mutant strain. The involvement of RegR in the regulation
of the PTS transporters and sugar-specific enzymes is possible,
however, it should be noted that the role of RegR in the
metabolism of sugars has beenminimized (Chapuy-Regaud et al.,
2003).
The non-synonymous mutations in the pyrimidine
biosynthetic genes carA, carB, and pyrDa (Figure 5) and
the differential expression of genes involved in the metabolism
of pyrimidines, in the spontaneous mutant D39SM, was a
positive surprise. A connection between capsule synthesis
and demand for uracil has been inferred (Carvalho, 2012;
Carvalho et al., 2013b). In this work, we identified a mutant
deficient in capsule production that shows downregulation of
a putative uracil transporter (spd_0267) and upregulation
of pyrC (spd_1030) (Figure 5), in a uracil-independent
manner. In other microorganisms the genes of the de novo
synthesis of pyrimidines are exclusively induced in the
absence of pyrimidines (Kilstrup et al., 2005; Turnbough
and Switzer, 2008). Therefore, the 5-fold induction of pyrC
in D39SM in medium containing uracil was a complete
surprise.
In S. pneumoniae, pyrC is in an operon containing two other
genes, spd_1032 (ung, uracil DNA-glycosylase) and spd_1031
(mutT protein), encoding functions involved in DNA repair
and trapping/removing of uracil residues from deoxyuridine
triphosphate (dUTP) precursors during replication (Chen and
Lacks, 1991). The transcriptome analysis might shed some light
on the event leading to the spontaneous generation of strain
D39SM. A plausible explanation could entail the induction of
the ung-mutT-pyrC operon by a stressful condition, followed
by changed pyrimidine availability, which would ultimately lead
to a suppressor cps promoter mutation. In accordance, the
spontaneous mutant D39SM exhibited lower accumulation of
UTP pools (data not shown) and uracil showed no effect on
growth and capsule expression and production of this strain.
The cps promoter point mutation and thus, the nearly or
entirely non-producing capsule phenotype, should improve the
bacterium fitness under a particular stressful condition. We
showed that this phenotype confers a competitive advantage
to strain D39SM when co-cultivated with its parent D39 in
uracil-free medium. In this light, in host niches poor in
uracil a predominance of underproducing capsule phenotypes
could be expected, suggesting that uracil would provide a
selective pressure. Pyrimidine bases and nucleosides are often
unavailable as exogenous nutrients, which most likely explain the
conservation of the genes of the de novo pathways for pyrimidine
biosynthesis in extracellular microorganisms (Turnbough and
Switzer, 2008). To our knowledge, in the human nasopharynx
and mucosal surfaces, rich in glycoproteins (e.g., mucins),
inorganic salts and water, where transparent variants and non-
capsule producers of S. pneumoniae are almost exclusively
found, information regarding pyrimidines availability is not
accessible in the literature. Curiously, pyrimidines, in particular
uridine, were detected in blood, where capsule is an absolute
requirement for the survival of S. pneumoniae. In healthy
men, the homeostatic concentration of uridine is about 3–4
µmol l−1 (Simmonds and Harkness, 1981). This concentration is
substantially lower than the standard initial uracil concentration
in our medium (82 µmol L−1). However, it might not be
limiting for growth since in the blood the uridine is quasi
constantly available. Replacement of uracil by uridine showed
no effect on batch cultures of strains D39 and D39SM (data not
shown).
In this work, we ascertained that expression of the capsule
operon and production of the polysaccharide in S. pneumoniae
is altered in response to uracil. A subtle interplay between
uracil metabolism, the pathways for pyrimidine synthesis and
the production of capsule is unveiled. In light of our results, we
propose that the sensing of pyrimidines by S. pneumoniae triggers
changes in capsule production. Exploring the mechanisms
integrating pyrimidine metabolism and capsule synthesis, in
particular, how regulation of capsule promoter expression is
mediated by pyrimidine intermediate(s) at the molecular level,
will certainly contribute to an improved understanding of
the regulatory phenomena underlying the control of capsule
synthesis, and ultimately virulence in the human pathogen S.
pneumoniae.
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